Cancer

Cancer

Any alcohol consumption raises cancer risk

Erin Brady

Jan. 6, 2025

New United States Surgeon General advisory.

Cancer

Connection between angiogenesis and drug resistance in breast cancer

LABline

Dec. 12, 2024

Cancer

In five cancer types, prevention and screening have been major contributors to saving lives

LABline

Dec. 6, 2024

Cancer

More cancers are being treated with personalized therapies before surgery

LABline

Dec. 4, 2024

Cancer

Enzyme identified as new therapeutic target for “cold” tumors

LABline

Dec. 4, 2024

Cancer

Diabetes drug appears to fight lung cancer — but only in overweight or obese patients

LABline

Nov. 26, 2024

Cancer

FDA grants accelerated approval to zanidatamab-hrii

LABline

Nov. 25, 2024

Approval for previously treated unresectable or metastatic HER2-positive biliary tract cancer.

Cancer

Owkin and Proscia expand access to AI pre-screening for colorectal cancer patients

LABline

Nov. 20, 2024

Partnership will assist pathologists in the pre-screening of patients with microsatellite stable (MSS) / proficient mismatch repair (pMMR) in colorectal tumors.

Cancer

Drug combination prompts immune response in some resistant pancreatic cancers

LABline

Nov. 15, 2024

New drug strategy studied by Johns Hopkins researchers.

Cancer

Vaccine shows promise against aggressive breast cancer

LABline

Nov. 14, 2024

Clinical trial targeted recurrence of hard-to-treat triple-negative breast cancer.

Cancer

Combination approach shows promise for treating rare, aggressive cancers

LABline

Nov. 13, 2024

UCLA research finds that combining immunotherapy with chemotherapy is safe and effective for people with advanced small cell cancers in the bladder and prostate.

Cancer

Curbing late-stage breast cancer diagnosis

LABline

Nov. 12, 2024

Mobile diagnostic kit aims to improve early detection in Uganda.

Cancer

Quitting smoking improves cancer survival

LABline

Nov. 8, 2024

Cancer patients who stop smoking within the first six months of diagnosis see improved longevity, study finds.

Cancer

Methylmalonic acid linked to weakening of immune cells in lung cancer

LABline

Nov. 8, 2024

Metabolic changes associated with aging can impact immune responses against tumors.

Cancer

Researchers report first published case of a patient with treatment-emergent neuroendocrine prostate cancer who showed a remarkable response to an anti-HER2 antibody-drug conjugate

LABline

Nov. 7, 2024

t-NEPC is an aggressive subtype of metastatic castration-resistant prostate cancer (mCRPC), and prior clinical trials with HER2-targeted therapies for mCRPC have failed to show...